I’m a Medical Doctor (MD) and public administration expert with over 20 years of experience dedicated to improving patient outcomes globally through clinical practice, health policy, advocacy, and healthcare management. My expertise spans cardiology, oncology, immunology, public health, and particularly rare diseases such as neurofibromatosis (NF). As Managing Director of the Children’s Tumor Foundation Europe, I lead initiatives focused on improving care, policy, and research collaboration for NF, driving meaningful partnerships across patient communities, clinical networks, EU institutions, and industry.
I’ve previously held senior roles in both government (Ministry of Health, Poland) and industry (Johnson & Johnson, Pfizer), where I successfully influenced health system reforms, including oncology, cardiology, family medicine, emergency medicine, health policy frameworks, coordinated clinical trials, and led high-level stakeholder engagement across the EMEA region. My experience includes developing national health programs, EU regulatory advocacy, clinical trials management, and patient-centered care strategies that have significantly enhanced access and care quality.
I am deeply committed to using policy, innovation, and collaboration to create tangible improvements for patients and healthcare systems. Let’s connect to discuss partnerships, advisory roles, or collaborative projects aimed at transforming healthcare for patients across Europe and beyond.
Lean management / line management
Main line management tasks: people development through trainings, coachings and sit-ins, performance assesments, resourcing
Main process improvment tasks: structured problem solving sessions, interface coordination, SOP reviews, assesments and updates, quality systems development
Main project delivery tasks: responsibility for project delivery within given timelines, budget and quality
Physician-scientist (MD) with over 20 years experience covering clinical care, early / translational & late drug development & executive leadership in global Oncology-Hematology & Immunology, regulatory submissions-approvals and commercialization. Special interest in development of targeted and novel therapies for severe diseases with unmet need. Maintains excellent network with the global medical & thought leader community as well as various specialists and consultants. Visionary, value-driven, passionate, sympathetic and efficient leader to bring along organizational transformation.
Dynamic and passionate biopharma leader with over 25 years of global expertise spanning clinical practice and R&D, and CROs. A problem-solver and strategist at heart, I thrive on tackling challenges. As a Managing Director and servant leader, I have driven operational excellence and transformed business critical processes. Through empathy and empowerment, I have led diverse international teams with less than 10% employee turnover.
In my current role, I saved over $2 million USD within six months through renegotiation and introduction of efficiencies, while doubling our satisfaction with vendors via introduction of governance structures and key performance, quality, and risk indicators.
Deeply committed to ethical and sustainable practices, I leverage data-driven decision-making to align vision, mission, and objectives with impactful outcomes. I bring energy, focus, and leadership to every initiative, ensuring excellence and meaningful contributions to healthcare.
A seasoned Clinical Research leader with 19 years of relevant experience in handling global clinical trials in multiple therapeutic areas- Oncology, Endocrinology, Immunology, Cardiology, Ophthalmology, Gastroenterology, Vaccines and Respiratory. Extensive experience in biosimilar development for more than 12 years
Tyler is a GTM manager at Legora and a thought leader on the development of collaborative AI solutions for financial services. Before joining Legora, Tyler was a strategy consultant at McKinsey and practiced as an M&A lawyer at Linklaters and Sullivan & Cromwell.
Keefe, a seasoned industry executive with over 30 years of experience, brings a wealth of knowledge in building and managing successful sales teams. His impressive career includes leadership roles at prominent companies such as Poly (Formerly Polycom), Westcon, Computacenter, Avaya, Citrix, and, most recently, Nuvias UC, where he served as Chief Revenue Officer and CEO.
Hishan Singhawansa oversees Cinnamon Hotels & Resorts in bringing the vision of ‘bringing the best of Sri Lanka to the world with style and elegance’ to life across hotel operations. Cinnamon Hotels & Resorts is a part of the Leisure industry group of John Keells Holdings PLC (JKH), Sri Lanka’s largest listed conglomerate, operating over 70 companies in 7 diverse industry sectors.
With more than 17 years of experience in business and operational efficiencies, Hishan is responsible for bringing people and capital together to support the company’s growth objectives by moving Cinnamon Hotels & Resorts through a journey of emotional hospitality, curated experiences, and empowering community development.
He currently leads the brand at a pivotal moment of strategic growth and regional expansion. The Group’s landmark development, Cinnamon Life, a US$1.2 billion investment, is a key milestone in the trajectory of positioning Colombo as a premier MICE and leisure destination in South Asia.
Hishan began his career in 2008 by joining JKH and its Retail sector, which overlooked multiple business units spanning supermarkets, logistics, and manufacturing. Following a progressive career path, he headed Category Management and Supply Chain before moving into the Leisure sector of the Group in 2017.
He holds an MBA from the University of Wales, London and a BSc Engineering (Hons) Degree from the University of Moratuwa, Sri Lanka.
Radhey Tawar specialises in strategy and execution of commercial performance and has diverse experience in various commercial functions. His professional career was built on Hospitality Management studies from Mumbai before the start of his career, followed by an on-site Revenue Management Certification from Cornell University, USA in 2005 and an MBA from the London Business School in 2012.
His career started with experience in uber-luxury brands like Rajvilas – an Oberoi Hotel in Jaipur and Burj-Al-Arab in Dubai. Expanding his experience within hospitality, Radhey ventured out to Revenue Management and other commercial roles with IHG in Dubai and India. Apart from Rooms, F&B and C&E Revenue Management with different IHG hotels based in UAE, his most notable roles were to lead the commercial function for new hotel openings for IHG hotels in India, the Middle East and Africa. From 2011 to 2015, he was involved with 15+ new hotel openings across different brands.
As the Chief Commercial Officer of Cinnamon Hotels & Resorts, Radhey Tawar oversees the development and execution of the company’s integrated commercial strategy, including the identification of new products and markets, revenue growth across all lines of business, brand marketing, global corporate reputation through public relations, the extensive digital ecosystem as well as establishing a global sales network.
In collaboration with the other executive leadership team members, Radhey is involved in all Cinnamon Hotels & Resorts customer experience touchpoints. He plays an integral role in the brand’s transition to being a luxury operator.
Besides spending quality time with his wife and three boys, Radhey loves outdoor running and is always up for a challenge participating in half or full marathons.
Theresa is a data scientist specializing in natural language processing (NLP) and machine learning (ML) for healthcare data. With a background in mathematics (B.S.) and data science (M.S.), she brings deep technical expertise in Python and SQL to the development of scalable, production-ready models. She currently leads a team of data scientists focused on building NLP and ML solutions that extract clinical insights from unstructured and semi-structured text within the Veradigm Network EHR (VNEHR). Her work supports Real World Evidence studies and client-facing analytics by transforming complex clinical narratives into structured, actionable data.
